Or if you're already a Pharma IQ member, sign in below to download. Sign In Join
With a population of 1.9 billion and a multi-medicine model, the reporting of adverse reactions in medicine in India is crucial. The pharmacovigilance programme was launched in India in 2010 to provide education about drug safety. Dr. Y.K Gupta, Co-ordinator of the national pharmacovigilance programme, India tells Pharma IQ how to overcome the obstacles to implemeting such a programme.
Have Your Say
Rate this feature and give us your feedback in the comments section below